We determined with confidence the mutational status for KRAS exon 2, BRAF exon 15, and PIK3CA exons 9 and 20 in 168 consecutive patients with mCRC, for whom a representative sample from the primary tumour was available for molecular analysis of DNA. Here, PIK3CA is linked to neoplasm.